BW

Applebee’s Celebrates Spring with $6 Cerveza & Sips

Say goodbye to winter with the latest Mucho CocktailsTM and Modelo Especial Draft at Applebee’s® GLENDALE, Calif.--(BUSINESS WIRE)--Spring forward with Applebee’s $6 Cerveza & Sips, the latest Mucho Cocktails made with premium spirits designed to cure the winter blues.* Make a splash with the Tipsy Shark – garnished with a…
Leer más...

Financial Times Acquires Majority Stake in Endpoints News

LAWRENCE, Kan.--(BUSINESS WIRE)--#biotech--The Financial Times has acquired a controlling stake in Endpoints News, a leading source of news and analysis for the thriving biopharmaceutical industry. Endpoints is the biopharma industry’s daily news source for science and innovation development, business deals and personnel moves. It has more than 163,000 subscribers and…
Leer más...

SHAREHOLDER ALERT (CVT) – Andrews & Springer LLC Is Seeking More Cash for Shareholders of Cvent Holding Corp.   

WILMINGTON, Del.--(BUSINESS WIRE)--Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Cvent Holding Corp. (NASDAQGM: CVT) (“Cvent” or the “Company”) relating to the sale of the Company to an…
Leer más...

Gartner Announces Keynote Speakers at 2023 Gartner Marketing Symposium/Xpo™

STAMFORD, Conn.--(BUSINESS WIRE)--#GartnerMKTG--Gartner, Inc. (NYSE: IT): What: Gartner Marketing Symposium/Xpo™ When: May 22-24, 2023 Where: Denver, CO Press registration: Members of the media can register for the conference by contacting katie.costello@gartner.com. 2023 Gartner Marketing Symposium/Xpo™ Theme: Prepare for Marketing’s New Directive In today’s unpredictable environment, marketing leaders’ growth strategies face…
Leer más...

Rallybio Announces Acceptance of Abstract for RLYB212 at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB) today announced that an abstract for RLYB212 reporting results from the Phase 1b proof-of-concept study has been accepted for presentation at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), which will take place in Montreal from June 24-28. RLYB212…
Leer más...

Scorpion Therapeutics Nominates STX-241 as Potentially Best-in-Class Fourth-Generation EGFR Inhibitor Development Candidate for the Treatment of Non-Small Cell Lung Cancer

-- STX-241 is a highly selective, CNS-penetrant, fourth generation epidermal growth factor receptor (“EGFR”) inhibitor designed to address resistance to third generation EGFR inhibitors -- -- Preclinical data to be presented in 2H 2023; investigational new drug (“IND”) application submission expected in 1H 2024 -- -- Third development candidate nominated…
Leer más...

Morgan Stanley Capital Partners Enters Agreement to Sell Ovation Fertility to US Fertility

NEW YORK--(BUSINESS WIRE)--Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), the middle-market focused private equity team at Morgan Stanley Investment Management, have entered into an agreement to sell Ovation Fertility (“Ovation”) to US Fertility (“USF”). Financial terms of the transaction were not disclosed. Ovation, headquartered in Nashville, Tennessee, is…
Leer más...